CCR10/CCL27 crosstalk contributes to failure of proteasome-inhibitors in multiple myeloma. [electronic resource]
Producer: 20180220Description: 78605-78618 p. digitalISSN:- 1949-2553
- Aged
- Apoptosis -- drug effects
- Bortezomib -- pharmacology
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Chemokine CCL27 -- metabolism
- Drug Resistance, Neoplasm
- Female
- Humans
- Interleukin-10 -- genetics
- Male
- Middle Aged
- Multiple Myeloma -- drug therapy
- Proteasome Endopeptidase Complex -- metabolism
- Proteasome Inhibitors -- pharmacology
- RNA Interference
- Receptor Cross-Talk -- drug effects
- Receptors, CCR10 -- genetics
- Receptors, Interleukin-10 -- genetics
- Signal Transduction -- drug effects
- Transfection
- Tumor Microenvironment
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.